Arix Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Arix Bioscience has a total shareholder equity of £239.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £240.5M and £1.4M respectively. Arix Bioscience's EBIT is £8.2M making its interest coverage ratio -2.4. It has cash and short-term investments of £101.0M.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | -2.4x |
| Cash | UK£100.99m |
| Equity | UK£239.12m |
| Total liabilities | UK£1.41m |
| Total assets | UK£240.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ARIXL's short term assets (£103.4M) exceed its short term liabilities (£1.4M).
Long Term Liabilities: ARIXL has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ARIXL is debt free.
Reducing Debt: ARIXL has not had any debt for past 5 years.
Debt Coverage: ARIXL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ARIXL has no debt, therefore coverage of interest payments is not a concern.